Clinical Trial Update: Adavosertib Plus Chemotherapy in Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating adavosertib in combination with chemotherapy for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Adavosertib (adavosertib)

Snippet

Sponsor: AstraZeneca | Conditions: Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation | Phase 2 | Status: COMPLETED | Results posted: 2019-11-22